About Investor Relations Team Contact Privacy Policy This privacy statement tells you what to expect when we collect your personal information. We will explain what data we hold about you, how we collect and use your data and whether we share it with other organisations. Pharma C Investments plc will be the organisation which has control of your data (the data controller). Pharma C Investments plc will not collect any personally identifiable information about you, for example, your name, address, telephone number or email address, unless you provide it to us voluntarily. Given that the Internet is a global environment, using the Internet to collect and process personal data necessarily involves the transmission of data on an international basis. Therefore, by browsing this website and communicating electronically with us, you acknowledge and agree to our processing of personal data in this way. If you have already submitted personal data and would like it removed from our records, please contact us at the e-mail address listed at the bottom of this section. USE OF INFORMATION Any information you provide to Pharma C Investments plc (“data”) will be put onto the Pharma C database and processed by us for marketing purposes, market research and in order to contact you or send you information. By submitting your data to us you agree to our storage and use of the data. SHARING OF INFORMATION Pharma C uses the above-described information to tailor our content to suit your needs. We will not disclose any information about any individual user except to comply with applicable law or valid legal process. Pharma C never shares information or data with any third parties. CHANGING OF PRIVACY POLICY By using this site, you consent to the collection and use of this information by Pharma C Investments. If we decide to change our Privacy Policy, we will post those changes on this page so that you are always aware of what information we collect, how we use it, and under what circumstances we disclose it. If you have submitted personal data through the site and would like that information deleted from our records, please contact us at: info@pharmacinvestments.com © Pharma C Investments PLC Cookie Policy Privacy Policy

About Investor Relations Team Contact Significant Holdings The Company has an issued share capital of 269,857,144 Ordinary Shares 259,857,144 Significant Shareholders As of 26 May 2021, the following had more than 3 per cent of the issued Share Capital Name Number of Ordinary Shares % of Share Capital Noel Lyons 26,700,000 9.89 Gavin Sathianathan* 23,300,000 8.63 Paul Ryan 23,000,001 8.52 Eugenio Marrapodi 22,000,000 8.15 Alan McLeish 16,671,700 6.18 Nicolas True 12,000,000 4.45 Sebastian Marr 11,114,467 4.12 Chris Simpson 10,000,000 3.71 *Director 72.95% of Pharma C’s ordinary shares are in public hands © Pharma C Investments PLC Cookie Policy Privacy Policy